CIK 0001157601
- Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 267-824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 4 Open-market buy Director bought 85,900 shares at an average $3.15 ($270,477)
- 4 Open-market buy President and CEO bought 10,000 shares at $3.05 ($30,530)
- 4 Open-market buy Director bought 115,292 shares at an average $2.90 ($333,777)
- 4 Grant or award VP, IP and Legal, Gen. Counsel acquired 5,284 shares (grant or award)
- 4 Grant or award VP, Fin. and Admin., CFO acquired 5,284 shares (grant or award)
- 4 Grant or award SVP, Chief Medical Officer acquired 7,477 shares (grant or award)
- 4 Grant or award Sr. VP, Drug Development acquired 8,224 shares (grant or award)
- 4 Grant or award Sr. VP, Pgm Mgmt and Clin Ops acquired 7,908 shares (grant or award)
- 4 Grant or award Sr. VP, Chief Comm. Officer acquired 8,627 shares (grant or award)
- 4 Grant or award President and CEO acquired 13,839 shares (grant or award)
- 5/A Insider Annual Insider Trading Report
- 5/A Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Open-market buy Director bought 550,000 shares at $4.50 ($2,475,000)
- 4 Open-market buy Director bought 100,000 shares at $4.50 ($450,000)
- 4 Open-market buy Director bought 100,000 shares at $4.50 ($450,000)
- 4 Open-market buy President and CEO bought 22,222 shares at $4.50 ($99,999)
- 4 Open-market buy Sr. VP, Drug Development bought 10,000 shares at $2.84 ($28,434)
- 4 Open-market buy 10% owner bought 20,000 shares at $2.88 ($57,600)
Page 24 of 29 · 564 filings